Bingzhong Wang - 28 Sep 2026 Form 4 Insider Report for Metalpha Technology Holding Ltd (MATH)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
29 Sep 2026, 09:22:04 UTC
Prior SEC filing
29 Sep 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Xiaosi Zhang, as Attorney-in-Fact for Bingzhong Wang

Key filing fact

Bingzhong Wang filed Form 4 for Metalpha Technology Holding Ltd (MATH) on 29 Sep 2026.

Key facts

  • This page summarizes Bingzhong Wang's Form 4 filing for Metalpha Technology Holding Ltd (MATH).
  • 2 reported transactions and 2 derivative rows are listed below.
  • Accepted by SEC: 29 Sep 2026, 09:22.

Change

  • Previous filing in this sequence was filed on 29 Sep 2026.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001979907 Primary reporting owner

Wang Bingzhong

Relationship
Chief Executive Officer, Director, 10%+ Owner
Address
C/O SUITE 5506-07, CENTRAL PLAZA 18 HARBOUR ROAD, WAN CHAI, HONG KONG
Signature
/s/ Xiaosi Zhang, as Attorney-in-Fact for Bingzhong Wang
Signature date
29 Sep 2026

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

MATH transaction Derivative

Restricted Share Units

Award

Transaction value
Shares
+1,000,000
Change %
Price
$0.000000*
Shares after
1,000,000
Date
28 Sep 2026
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount
1,000,000
Exercise price
$0.000000
Footnotes
F1
MATH transaction Derivative

Restricted Share Units

Award

Transaction value
Shares
+727,000
Change %
Price
$0.000000*
Shares after
727,000
Date
28 Sep 2026
Ownership
By Spouse
Underlying class
Ordinary Shares
Underlying amount
727,000
Exercise price
$0.000000
Footnotes
F2
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Represents 1,000,000 restricted share units ("RSUs") granted to the Reporting Person on September 28, 2026 under the Company's Amended and Restated 2024 Share Incentive Plan, without additional consideration paid by the Reporting Person. Each RSU represents a contingent right to receive one Ordinary Share. The RSUs vest in four equal installments on the day following each anniversary of the grant date, commencing on September 29, 2027 and vesting in full on September 29, 2030, subject to the Reporting Person's continued service to the Issuer.

Footnote F2

Represents 727,000 RSUs granted to the Reporting Person's spouse, on September 28, 2026 under the Company's Amended and Restated 2024 Share Incentive Plan, without additional consideration paid by the Reporting Person's spouse. Each RSU represents a contingent right to receive one Ordinary Share. The RSUs vest in four equal installments on the day following each anniversary of the grant date, commencing on September 29, 2027 and vesting in full on September 29, 2030, subject to the continued service of the Reporting Person's spouse to the Issuer. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .